Non-invasive continuous blood pressure monitoring systems: current and proposed technology issues and challenges

被引:0
作者
Solmaz Rastegar
Hamid GholamHosseini
Andrew Lowe
机构
[1] Auckland University of Technology,School of Engineering, Computer, and Mathematical Sciences
来源
Physical and Engineering Sciences in Medicine | 2020年 / 43卷
关键词
Continuous blood pressure monitoring; Cuff-less; Non-invasive; Pulse transit time; Pulse arrival time;
D O I
暂无
中图分类号
学科分类号
摘要
High blood pressure (BP) or hypertension is the single most crucial adjustable risk factor for cardiovascular diseases (CVDs) and monitoring the arterial blood pressure (ABP) is an efficient way to detect and control the prevalence of the cardiovascular health of patients. Therefore, monitoring the regulation of BP during patients’ daily life plays a critical role in the ambulatory setting and the latest mobile health technology. In recent years, many studies have been conducted to explore the feasibility and performance of such techniques in the health care system. The ultimate aim of these studies is to find and develop an alternative to conventional BP monitoring by using cuff-less, easy-to-use, fast, and cost-effective devices for controlling and lowering the physical harm of CVDs to the human body. However, most of the current studies are at the prototype phase and face a range of issues and challenges to meet clinical standards. This review focuses on the description and analysis of the latest continuous and cuff-less methods along with their key challenges and barriers. Particularly, most advanced and standard technologies including pulse transit time (PTT), ultrasound, pulse arrival time (PAT), and machine learning are investigated. The accuracy, portability, and comfort of use of these technologies, and the ability to integrate to the wearable healthcare system are discussed. Finally, the future directions for further study are suggested.
引用
收藏
页码:11 / 28
页数:17
相关论文
共 341 条
[1]  
Chobanian AV(2003)Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure Hypertension 42 1206-1252
[2]  
Bakris GL(2009)Blood-pressure measurement N Engl J Med 360 e6-247
[3]  
Black HR(2014)Cardiovascular risk assessment in low-resource settings: a consensus document of the European Society of Hypertension Working Group on Hypertension and Cardiovascular Risk in Low Resource Settings J Hypertens 32 951-2323
[4]  
Cushman WC(2002)The heart, kidney, and brain as target organs in hypertension Cardiol Clin 20 225-968
[5]  
Green LA(2015)Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the global burden of disease study 2013 Lancet 386 2287-2260
[6]  
Izzo JL(2013)Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high, middle, and low-income countries JAMA 310 959-2374
[7]  
Jones DW(2012)A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the global burden of disease study 2010 Lancet 380 2224-410
[8]  
Materson BJ(2006)Ambulatory blood-pressure monitoring N Engl J Med 354 2368-2116
[9]  
Oparil S(2013)2013 Ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals: joint recommendations from the International Society for Chronobiology (ISC), American Association of Medical Chronobiology and Chronotherapeutics (AAMCC), Spanish Society of Applied Chronobiology, Chronotherapy, and Vascular Risk (SECAC) Chronobiol Int 30 355-1554
[10]  
Wright JT(2015)A randomized trial of intensive versus standard blood-pressure control N Engl J Med 2015 2103-455